NPR logo

Doctors, Patients Seek Answers on Painkiller Risks

  • Download
  • <iframe src="https://www.npr.org/player/embed/4500447/4500574" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Doctors, Patients Seek Answers on Painkiller Risks

Health Care

Doctors, Patients Seek Answers on Painkiller Risks

Doctors, Patients Seek Answers on Painkiller Risks

  • Download
  • <iframe src="https://www.npr.org/player/embed/4500447/4500574" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

With sales of Cox-2 inhibitors declining, it's far from clear who would pay for the expensive safety studies needed to gather information on risks and safe dosages. hide caption

Expanded Chart: Declining Sales of Cox-2 Inhibitors
toggle caption

The FDA is weighing the safety of Celebrex, Bextra and Aleve in the wake of studies suggesting this class of drugs, known as Cox-2 inhibitors, may be dangerous. But some patients say they aren't getting enough pain relief without the drugs. Doctors want more studies to help define who's at risk and what's a safe dose.